SCHEMBL9103580

SCHEMBL9103580

COc1ccc(-c2ccnc3c(C(=O)N[C@H]4CC[C@H](NC(=O)[C@H](C)O)CC4)c(C)[nH]c23)c(OCC2CC2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
AURKA O14965 1/20 0.35
MET P08581 1/20 0.35
KDR P35968 1/20 0.35
TEK Q02763 1/20 0.35
CDK9 P50750 2/20 0.35
CASP3 P42574 1/20 0.35
CASP7 P55210 1/20 0.35
CDK1 P06493 1/20 0.35
CDK2 P24941 1/20 0.35
RIPK2 O43353 1/20 0.35
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34
CRHR1 P34998 2/20 0.34
CRHR2 Q13324 2/20 0.34
ROCK2 O75116 1/20 0.34
MELK Q14680 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9105966 1.00 ACACB (0.37) ACACBGRIN1GRIN2BAURKAMET
SCHEMBL9103593 1.00 ACACB (0.37) ACACBGRIN1GRIN2BAURKAMET
SCHEMBL9106861 0.94 GABRG2 (0.37) ACACBGRIN1GRIN2BAURKAMET
SCHEMBL9106867 0.94 GABRG2 (0.37) ACACBGRIN1GRIN2BAURKAMET
SCHEMBL9104889 0.91 GRIN1 (0.38) GRIN1GRIN2BAURKAMETKDR
SCHEMBL9104922 0.91 GRIN1 (0.38) GRIN1GRIN2BAURKAMETKDR
SCHEMBL9104910 0.91 GRIN1 (0.38) GRIN1GRIN2BAURKAMETKDR
SCHEMBL9106102 0.91 CDK9 (0.41) ACACBGRIN1GRIN2BCDK9CASP3
SCHEMBL9107667 0.91 CDK9 (0.41) ACACBGRIN1GRIN2BCDK9CASP3
SCHEMBL9106095 0.91 CDK9 (0.41) ACACBGRIN1GRIN2BCDK9CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US claimed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US claimed
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US disclosed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A ACACB 3646/4885GRIN1 2326/4885GRIN2B 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.